Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pirus Ghadjar

Showing results (81-90 of 187) with videos related to

Pageof 19
Sort By:
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|October 10, 2018
Neoadjuvant chemotherapy plus radiation versus chemotherapy plus regional hyperthermia in high-grade soft tissue sarcomas: a retrospective comparisonSebastian Zschaeck, Peter Wust, Ingo Melcher, et al.
International Journal of Radiation Oncology, Biology, Physics|March 17, 2010
Incidence of small lymph node metastases with evidence of extracapsular extension: clinical implications in patients with head and neck squamous cell carcinomaPirus Ghadjar, Mathew Simcock, Heide Schreiber-Facklam, et al.
Journal of Translational Medicine|May 13, 2010
CCL20/CCR6 expression profile in pancreatic cancerClaudia Rubie, Vilma Oliveira Frick, Pirus Ghadjar, et al.
Radiation Oncology (London, England)|January 16, 2014
Multimodal treatment for high-risk prostate cancer with high-dose intensity-modulated radiation therapy preceded or not by radical prostatectomy, concurrent intensified-dose docetaxel and long-term androgen deprivation therapy: results of a prospective phase II trialAndrea Guttilla, Roberto Bortolus, Gianluca Giannarini, et al.
Radiation Oncology (London, England)|December 21, 2018
Locally dose-escalated radiotherapy may improve intracranial local control and overall survival among patients with glioblastomaSebastian Zschaeck, Peter Wust, Reinhold Graf, et al.
World Journal of Gastroenterology|September 14, 2011
Effect of preoperative FOLFOX chemotherapy on CCL20/CCR6 expression in colorectal liver metastasesClaudia Rubie, Vilma Oliveira Frick, Pirus Ghadjar, et al.
Radiation Oncology (London, England)|June 3, 2014
Late toxicity and five year outcomes after high-dose-rate brachytherapy as a monotherapy for localized prostate cancerPirus Ghadjar, Sebastian L Oesch, Cyrill A Rentsch, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 8, 2016
Unilateral and bilateral neck SIB for head and neck cancer patients : Intensity-modulated proton therapy, tomotherapy, and RapidArcCarmen Stromberger, Luca Cozzi, Volker Budach, et al.
Journal of Cancer Research and Clinical Oncology|May 10, 2008
Chemokine receptor CCR6 expression level and aggressiveness of prostate cancerPirus Ghadjar, Christoph Loddenkemper, Sarah Ellen Coupland, et al.
Radiation Oncology (London, England)|March 17, 2021
Radiotherapeutic treatment options for oligotopic malignant liver lesionsPeter Wust, Marcus Beck, Robert Dabrowski, et al.
Pageof 19

Showing results (81-90 of 187) with videos related to

Sort By:
Pageof 19
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|October 10, 2018
Neoadjuvant chemotherapy plus radiation versus chemotherapy plus regional hyperthermia in high-grade soft tissue sarcomas: a retrospective comparisonSebastian Zschaeck, Peter Wust, Ingo Melcher, et al.
International Journal of Radiation Oncology, Biology, Physics|March 17, 2010
Incidence of small lymph node metastases with evidence of extracapsular extension: clinical implications in patients with head and neck squamous cell carcinomaPirus Ghadjar, Mathew Simcock, Heide Schreiber-Facklam, et al.
Journal of Translational Medicine|May 13, 2010
CCL20/CCR6 expression profile in pancreatic cancerClaudia Rubie, Vilma Oliveira Frick, Pirus Ghadjar, et al.
Radiation Oncology (London, England)|January 16, 2014
Multimodal treatment for high-risk prostate cancer with high-dose intensity-modulated radiation therapy preceded or not by radical prostatectomy, concurrent intensified-dose docetaxel and long-term androgen deprivation therapy: results of a prospective phase II trialAndrea Guttilla, Roberto Bortolus, Gianluca Giannarini, et al.
Radiation Oncology (London, England)|December 21, 2018
Locally dose-escalated radiotherapy may improve intracranial local control and overall survival among patients with glioblastomaSebastian Zschaeck, Peter Wust, Reinhold Graf, et al.
World Journal of Gastroenterology|September 14, 2011
Effect of preoperative FOLFOX chemotherapy on CCL20/CCR6 expression in colorectal liver metastasesClaudia Rubie, Vilma Oliveira Frick, Pirus Ghadjar, et al.
Radiation Oncology (London, England)|June 3, 2014
Late toxicity and five year outcomes after high-dose-rate brachytherapy as a monotherapy for localized prostate cancerPirus Ghadjar, Sebastian L Oesch, Cyrill A Rentsch, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 8, 2016
Unilateral and bilateral neck SIB for head and neck cancer patients : Intensity-modulated proton therapy, tomotherapy, and RapidArcCarmen Stromberger, Luca Cozzi, Volker Budach, et al.
Journal of Cancer Research and Clinical Oncology|May 10, 2008
Chemokine receptor CCR6 expression level and aggressiveness of prostate cancerPirus Ghadjar, Christoph Loddenkemper, Sarah Ellen Coupland, et al.
Radiation Oncology (London, England)|March 17, 2021
Radiotherapeutic treatment options for oligotopic malignant liver lesionsPeter Wust, Marcus Beck, Robert Dabrowski, et al.
Pageof 19